May I ask how, in your opinion, MSB should have gone about getting an appropriate historical control in a heteogeneous condition that's not particularly common and targeting a subset of that, a condition where grading and assessment have been historically subjective and unreliable?
Also, may I ask what Incyte used for their historical control that resulted in FDA approval in a similar single-arm trial?
- Forums
- ASX - By Stock
- AFR reports that the co to be sued for its promotional announcements.
MSB
mesoblast limited
Add to My Watchlist
5.07%
!
$1.78

May I ask how, in your opinion, MSB should have gone about...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.78 |
Change
-0.095(5.07%) |
Mkt cap ! $2.274B |
Open | High | Low | Value | Volume |
$1.84 | $1.84 | $1.77 | $6.044M | 3.352M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 13980 | $1.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 43363 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 26164 | 1.775 |
27 | 38624 | 1.770 |
9 | 30005 | 1.765 |
14 | 149204 | 1.760 |
12 | 70613 | 1.755 |
Price($) | Vol. | No. |
---|---|---|
1.780 | 12140 | 13 |
1.785 | 50072 | 21 |
1.790 | 53456 | 8 |
1.795 | 61436 | 8 |
1.800 | 44563 | 9 |
Last trade - 14.28pm 04/04/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
AUK
AUMAKE LIMITED.
CEO Hai Yun Chen, Non-Executive Chairman Anthony Noble
CEO Hai Yun Chen
Non-Executive Chairman Anthony Noble
SPONSORED BY The Market Online